Medtronic Minimally Invasive Therapies is building its gastrointestinal device foundation with the planned purchase of capsule-based endoscopy provider Given Imaging Ltd. for a net price of $860 million. With the deal, Covidien is betting on near-term FDA approval of Given’s PillCam technology to help diagnose colon cancer to drive growth.
“Adding Given’s portfolio of diagnostics to our portfolio accelerates Covidien’s strategy of providing physicians with products that support the patient along the care continuum from diagnosis to treatment
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?